Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Lubiprostone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 776,985Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US

    02 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218640

    FDA
    02 Jan 2025
    Share Share
    Takeda hit with another pay-for-delay lawsuit
    Takeda hit with another pay-for-delay lawsuit

    13 Apr 2023

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/takeda-hit-another-pay-delay-lawsuit-time-colcrys

    Eric Sagonowsky FIERCE PHARMA
    13 Apr 2023
    Share Share
    Zydus Life gets USFDA nod for Lubiprostone capsules
    Zydus Life gets USFDA nod for Lubiprostone capsules

    25 Mar 2023

    // BUSINESS STANDARD

    https://www.business-standard.com/article/news-cm/zydus-life-gets-usfda-nod-for-lubiprostone-capsules-123032400856_1.html#:~:text=Zydus%20Lifesciences%20said%20that%20it,reference%20listed%20drug%2C%20Amitiza%20capsules.

    BUSINESS STANDARD
    25 Mar 2023
    Share Share
    Dr. Reddy's Generic Lubiprostone Receives Approval in the U.S.
    Dr. Reddy's Generic Lubiprostone Receives Approval in the U.S.

    08 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206994

    FDA
    08 Feb 2022
    Share Share
    Teva Pharms' Generic Lubiprostone Receives Approval in the U.S.
    Teva Pharms' Generic Lubiprostone Receives Approval in the U.S.

    18 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209920

    FDA
    18 Jan 2022
    Share Share
    Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount
    Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount

    07 Sep 2019

    // K. Blankenship FIERCEPHARMA

    https://www.fiercepharma.com/pharma/mallinckrodt-investors-stream-for-exits-as-opioid-tied-bankruptcy-talk-mounts

    K. Blankenship FIERCEPHARMA
    07 Sep 2019
    Share Share